Latonia Wilkins knows she needs to be on PrEP due to her non-monogamous lifestyle. But the 52-year-old Atlanta mother has faced repeated challenges getting the lifesaving drug that can prevent new HIV infections.
MSD secures worldwide license for LaNova’s LM-299
The agreement is set to conclude in Q4 2024. Credit: Merck & Co. MSD has secured an exclusive worldwide license from LaNova Medicines for developing,